Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Sella, Tal"'
Autor:
Rosenberg SM; Department of Population Health Sciences, Weill Cornell Medicine, 402 E 67St LA-0005, New York, NY, 10065, USA. shr4009@med.cornell.edu.; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. shr4009@med.cornell.edu.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA. shr4009@med.cornell.edu.; Harvard Medical School, Boston, MA, USA. shr4009@med.cornell.edu., Zheng Y; Data Science, Dana-Farber Cancer Institute, Boston, MA, USA., Gelber S; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA., Ruddy KJ; Medical Oncology, Mayo Clinic, Rochester, MN, USA., Poorvu P; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Sella T; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Tamimi RM; Department of Population Health Sciences, Weill Cornell Medicine, 402 E 67St LA-0005, New York, NY, 10065, USA., Wassermann J; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA.; Department of Medical Oncology, Sorbonne Université, IUC, Pitié-Salpêtrière University Hospital, Paris, AP-HP, France., Schapira L; Department of Medicine, Division of Medical Oncology, Stanford University, Stanford, CA, USA., Borges VF; Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA., Come S; Harvard Medical School, Boston, MA, USA.; Medical Oncology, Beth Israel Deaconess Medical Center, Boston, MA, USA., Peppercorn J; Harvard Medical School, Boston, MA, USA.; Department of Medicine, Division of Medical Oncology, Massachusetts General Hospital, Boston, MA, USA., Sepucha KR; Harvard Medical School, Boston, MA, USA.; Department of Medicine, Division of Medical Oncology, Massachusetts General Hospital, Boston, MA, USA., Partridge AH; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.
Publikováno v:
Breast cancer research and treatment [Breast Cancer Res Treat] 2023 Feb; Vol. 197 (3), pp. 547-558. Date of Electronic Publication: 2022 Nov 27.
Autor:
Sella T; Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, USA., Exman P; Hospital Alemão Oswaldo Cruz, Sao Paulo, Brazil., Ren S; Data Science, Dana-Farber Cancer Institute, Boston, MA, USA., Freret TS; Division of Maternal-Fetal Medicine, Brigham and Women's Hospital, Boston, MA, USA., Economy KE; Division of Maternal-Fetal Medicine, Brigham and Women's Hospital, Boston, MA, USA., Chen WY; Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, USA., Parsons HA; Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, USA., Lin NU; Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, USA., Moy B; Medical Oncology, Massachusetts General Hospital, Boston, MA, USA., Tung NM; Medical Oncology, Beth Israel Deaconess Medical Center, Boston, MA, USA., Partridge AH; Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, USA., Tayob N; Data Science, Dana-Farber Cancer Institute, Boston, MA, USA., Mayer EL; Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, USA. emayer@partners.org.
Publikováno v:
Breast cancer research and treatment [Breast Cancer Res Treat] 2022 Aug; Vol. 194 (3), pp. 597-606. Date of Electronic Publication: 2022 Jun 17.
Autor:
Sella T; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA., Kantor O; Harvard Medical School, Boston, MA, USA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA.; Division of Breast Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, MA, USA., Weiss A; Harvard Medical School, Boston, MA, USA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA.; Division of Breast Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, MA, USA., Partridge AH; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA., Metzger O; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA., King TA; Harvard Medical School, Boston, MA, USA. tking7@bwh.harvard.edu.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA. tking7@bwh.harvard.edu.; Division of Breast Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, MA, USA. tking7@bwh.harvard.edu.
Publikováno v:
Breast cancer research and treatment [Breast Cancer Res Treat] 2022 Aug; Vol. 194 (3), pp. 663-672. Date of Electronic Publication: 2022 Jun 25.
Autor:
Ruddy KJ; Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA. ruddy.kathryn@mayo.edu., Zheng Y; Dana-Farber Cancer Institute, Boston, USA., Tayob N; Dana-Farber Cancer Institute, Boston, USA., Hu J; Dana-Farber Cancer Institute, Boston, USA., Dang CT; Memorial Sloan Kettering Cancer Center, New York, USA., Yardley DA; Tennessee Oncology, Nashville, USA., Isakoff SJ; Massachussetts General Hospital, Boston, USA., Valero VV; MD Anderson Cancer Center, Houston, USA., Faggen MG; Dana-Farber Cancer Institute, Boston, USA., Mulvey TM; Massachussetts General Hospital, Boston, USA., Bose R; Siteman Cancer Center, St. Louis, USA., Sella T; Dana-Farber Cancer Institute, Boston, USA., Weckstein DJ; New Hampshire Oncology and Hematology, Hooksett, USA., Wolff AC; Johns Hopkins University, Baltimore, USA., Reeder-Hayes KE; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, USA., Rugo HS; Diller Family Comprehensive Cancer Center, University of California San Francisco Helen, San Francisco, USA., Ramaswamy B; Ohio State University Comprehensive Cancer Center, Columbus, USA., Zuckerman DS; St. Luke's Mountain States Tumor Institute, Boise, USA., Hart LL; Florida Cancer Specialists, Brandon, USA., Gadi VK; University of Illinois At Chicago, Chicago, USA., Constantine M; Dana-Farber Cancer Institute, Boston, USA., Cheng KL; Northwell Health, New York, USA., Briccetti FM; Dana-Farber Cancer Institute, Boston, USA., Schneider BP; Indiana University School of Medicine, Indianapolis, USA., Merrill Garrett A; Eastern Maine Medical Center, Bangor, USA., Kelly Marcom P; Duke University, Durham, USA., Albain KS; Loyola University Medical Center, Maywood, USA., DeFusco PA; Hartford HealthCare Cancer Institute, Avon, USA., Tung NM; Beth Israel Deaconess Medical Center, Boston, USA., Ardman BM; Lowell General Hospital, Lowell, USA., Nanda R; University of Chicago, Chicago, USA., Jankowitz RC; Penn Medicine Abramson Cancer Center, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA., Rimawi M; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, USA., Abramson V; Vanderbilt-Ingram Cancer Center, Nashville, TN, USA., Pohlmann PR; Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, USA., Van Poznak C; Rogel Cancer Center, University of Michigan, Ann Arbor, MI, USA., Forero-Torres A; Kirklin UAB Hematology Oncology, Birmingham, AL, USA., Liu MC; Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA., Rosenberg S; Dana-Farber Cancer Institute, Boston, USA., DeMeo MK; Dana-Farber Cancer Institute, Boston, USA., Burstein HJ; Dana-Farber Cancer Institute, Boston, USA., Winer EP; Dana-Farber Cancer Institute, Boston, USA., Krop IE; Dana-Farber Cancer Institute, Boston, USA., Partridge AH; Dana-Farber Cancer Institute, Boston, USA., Tolaney SM; Dana-Farber Cancer Institute, Boston, USA.
Publikováno v:
Breast cancer research and treatment [Breast Cancer Res Treat] 2021 Aug; Vol. 189 (1), pp. 103-110. Date of Electronic Publication: 2021 Jun 12.
Autor:
Sella T; Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA.; Harvard Medical School, Boston, MA, USA., Gelber SI; Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA., Poorvu PD; Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA.; Harvard Medical School, Boston, MA, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA., Kim HJ; Asan Medical Center, Seoul, Korea., Dominici L; Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA.; Harvard Medical School, Boston, MA, USA.; Divison of Breast Surgery Department of Surgery, Brigham and Women's Hospital, Boston, MA, USA., Guzman-Arocho YD; Harvard Medical School, Boston, MA, USA.; Beth Israel Deaconess Medical Center, Boston, MA, USA., Collins L; Harvard Medical School, Boston, MA, USA.; Beth Israel Deaconess Medical Center, Boston, MA, USA., Ruddy KJ; Mayo Clinic, Department of Oncology, Rochester, MN, USA., Tamimi RM; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.; Department of Population Health Sciences, Weill Cornell Medicine, New York, NY, USA., Peppercorn JM; Harvard Medical School, Boston, MA, USA.; Massachusetts General Hospital, Boston, MA, USA., Schapira L; Stanford Cancer Institute, Palo Alto, CA, USA., Borges VF; University of Colorado Comprehensive Cancer Center, Aurora, CO, USA., Come SE; Harvard Medical School, Boston, MA, USA.; Beth Israel Deaconess Medical Center, Boston, MA, USA., Warner E; Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada., Snow C; Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA., Jakubowski DM; Genomic Health, Redwood City, CA, USA., Russell CA; Genomic Health, Redwood City, CA, USA., Winer EP; Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA.; Harvard Medical School, Boston, MA, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA., Rosenberg SM; Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA.; Harvard Medical School, Boston, MA, USA., Partridge AH; Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA. Ann_partridge@dfci.harvard.edu.; Harvard Medical School, Boston, MA, USA. Ann_partridge@dfci.harvard.edu.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA. Ann_partridge@dfci.harvard.edu.
Publikováno v:
Breast cancer research and treatment [Breast Cancer Res Treat] 2021 Feb; Vol. 186 (1), pp. 157-165. Date of Electronic Publication: 2020 Nov 04.